Abstract
BACKGROUND: The utility of cytomegalovirus (CMV) urine cultures was checked in patients with HIV (a) to identify those at risk for CMV retinitis and (b) to guide clinical decisions on treatment and prophylaxis of CMV retinitis. METHODS: HIV infected patients were tested for CMVuria by shell vial cell cultures. The prevalence of CMVuria was related to CD4 count, HIV risk group, and time before and after diagnosis of CMV retinitis. RESULTS: A total of 639 shell vial cell cultures were obtained from 266 HIV infected ophthalmic patients. Only 4% of all patients with a CD4 count > 400 x 10(6)/l shed CMV in their urine compared with 42% with a CD4 count < or = 50 x 10(6)/l. Twenty three of 25 patients with CMV retinitis had a CD4 count < or = 50 x 10(6)/l. Among 130 patients with a CD4 count < or = 50 x 10(6)/l (a) those who were CMVuric had a nearly sevenfold risk (p < 0.0001) of developing CMV retinitis (35%) compared with those who did not shed CMV in their urine (5%), and (b) CMVuria and CMV retinitis were more frequent in homosexuals (58%/25%) than in intravenous drug users (23%/15%). More than 1 year before diagnosis of CMV retinitis 18% of patients were CMVuric compared with 83% of patients who were CMV culture positive in the last 3 months. CMVuria under virustatic maintenance therapy is associated with worsening of retinitis in two thirds of cases. CONCLUSION: Ophthalmic screening of patients with HIV should include those with a CD4 count < or = 50 x 10(6)/l and focus on the subgroup with additional CMVuria. Screening of other patients can be dropped without undue risk in order to spare AIDS patients unnecessary hospital visits. CMVuria as a single finding, however, does not justify antiviral prophylaxis of CMV retinitis.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cheong I., Flegg P. J., Brettle R. P., Welsby P. D., Burns S. M., Dhillon B., Leen C. L., Gray J. A. Cytomegalovirus disease in AIDS: the Edinburgh experience. Int J STD AIDS. 1992 Sep-Oct;3(5):324–328. doi: 10.1177/095646249200300504. [DOI] [PubMed] [Google Scholar]
- Crowe S. M., Carlin J. B., Stewart K. I., Lucas C. R., Hoy J. F. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 1991;4(8):770–776. [PubMed] [Google Scholar]
- Dhillon B. The management of cytomegalovirus retinitis in AIDS. Br J Ophthalmol. 1994 Jan;78(1):66–69. doi: 10.1136/bjo.78.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drew W. L., Mills J., Lèvy J., Dylewski J., Casavant C., Ammann A. J., Brodie H., Merigan T. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med. 1985 Jul;103(1):61–63. doi: 10.7326/0003-4819-103-1-61. [DOI] [PubMed] [Google Scholar]
- Drew W. L., Mintz L., Miner R. C., Sands M., Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981 Feb;143(2):188–192. doi: 10.1093/infdis/143.2.188. [DOI] [PubMed] [Google Scholar]
- Erice A., Holm M. A., Gill P. C., Henry S., Dirksen C. L., Dunn D. L., Hillam R. P., Balfour H. H., Jr Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol. 1992 Nov;30(11):2822–2825. doi: 10.1128/jcm.30.11.2822-2825.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
- Freymuth F., Gennetay E., Petitjean J., Eugene G., Hurault de Ligny B., Ryckelynck J. P., Legoff C., Hazera P., Bazin C. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J Clin Microbiol. 1994 Jun;32(6):1614–1618. doi: 10.1128/jcm.32.6.1614-1618.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallant J. E., Moore R. D., Chaisson R. E. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994 Jun 1;120(11):932–944. doi: 10.7326/0003-4819-120-11-199406010-00006. [DOI] [PubMed] [Google Scholar]
- Garweg J. Opportunistische Augenerkrankungen im Rahmen der HIV-Infektion. Klin Monbl Augenheilkd. 1993 May;202(5):465–470. doi: 10.1055/s-2008-1045630. [DOI] [PubMed] [Google Scholar]
- Geier S. A., Gürtler L., Klauss V., Mueller A., Bader L., Eberle J., Bogner J. J., Kronawitter U., Goebel F. D., Lund O. E. Unterschiede in der Nachweisbarkeit von Humanem Immunschwäche Virus Typ 1 in Tränenflüssigkeit und Blutlymphozyten. Klin Monbl Augenheilkd. 1992 Sep;201(3):164–168. doi: 10.1055/s-2008-1045886. [DOI] [PubMed] [Google Scholar]
- Gerna G., Parea M., Percivalle E., Zipeto D., Silini E., Barbarini G., Milanesi G. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS. 1990 Oct;4(10):1027–1031. doi: 10.1097/00002030-199010000-00014. [DOI] [PubMed] [Google Scholar]
- Gleaves C. A., Smith T. F., Shuster E. A., Pearson G. R. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985 Feb;21(2):217–221. doi: 10.1128/jcm.21.2.217-221.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holland G. N., Pepose J. S., Pettit T. H., Gottlieb M. S., Yee R. D., Foos R. Y. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology. 1983 Aug;90(8):859–873. doi: 10.1016/s0161-6420(83)80009-8. [DOI] [PubMed] [Google Scholar]
- Kuppermann B. D., Petty J. G., Richman D. D., Mathews W. C., Fullerton S. C., Rickman L. S., Freeman W. R. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 May 15;115(5):575–582. doi: 10.1016/s0002-9394(14)71453-9. [DOI] [PubMed] [Google Scholar]
- McCarthy M. Oral ganciclovir fails to prevent CMV in HIV trial. Lancet. 1995 Sep 30;346(8979):895–895. doi: 10.1016/s0140-6736(95)92726-3. [DOI] [PubMed] [Google Scholar]
- Palestine A. G., Rodrigues M. M., Macher A. M., Chan C. C., Lane H. C., Fauci A. S., Masur H., Longo D., Reichert C. M., Steis R. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984 Sep;91(9):1092–1099. doi: 10.1016/s0161-6420(84)34201-4. [DOI] [PubMed] [Google Scholar]
- Revello M. G., Percivalle E., Sarasini A., Baldanti F., Furione M., Gerna G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis. 1994 Nov;170(5):1275–1279. doi: 10.1093/infdis/170.5.1275. [DOI] [PubMed] [Google Scholar]
- Salmon D., Lacassin F., Harzic M., Leport C., Perronne C., Bricaire F., Brun-Vezinet F., Vilde J. L. Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol. 1990 Nov;32(3):160–163. doi: 10.1002/jmv.1890320306. [DOI] [PubMed] [Google Scholar]
- Welby S. B., Rogerson S. J., Beeching N. J. Autonomic neuropathy is common in human immunodeficiency virus infection. J Infect. 1991 Sep;23(2):123–128. doi: 10.1016/0163-4453(91)91958-z. [DOI] [PubMed] [Google Scholar]
- Zurlo J. J., O'Neill D., Polis M. A., Manischewitz J., Yarchoan R., Baseler M., Lane H. C., Masur H. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med. 1993 Jan 1;118(1):12–17. doi: 10.7326/0003-4819-118-1-199301010-00003. [DOI] [PubMed] [Google Scholar]
